Waverly Advisors LLC Grows Stock Position in Colgate-Palmolive Company $CL

Waverly Advisors LLC boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 6.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 180,975 shares of the company’s stock after purchasing an additional 10,832 shares during the period. Waverly Advisors LLC’s holdings in Colgate-Palmolive were worth $16,592,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Empirical Finance LLC boosted its stake in shares of Colgate-Palmolive by 3.3% during the 2nd quarter. Empirical Finance LLC now owns 29,035 shares of the company’s stock worth $2,662,000 after acquiring an additional 936 shares in the last quarter. Nykredit A S acquired a new stake in Colgate-Palmolive during the 2nd quarter worth $22,146,000. Range Advisory LLC purchased a new stake in Colgate-Palmolive during the 2nd quarter valued at about $276,000. Corient Private Wealth LP grew its position in shares of Colgate-Palmolive by 29.0% in the second quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock valued at $58,639,000 after purchasing an additional 143,812 shares in the last quarter. Finally, Amundi increased its stake in shares of Colgate-Palmolive by 19.9% in the 2nd quarter. Amundi now owns 6,218,257 shares of the company’s stock worth $570,090,000 after acquiring an additional 1,033,918 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.5%

NYSE CL opened at $88.37 on Wednesday. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The firm’s fifty day moving average price is $91.75 and its 200 day moving average price is $89.72. The company has a market capitalization of $70.45 billion, a price-to-earnings ratio of 35.07, a price-to-earnings-growth ratio of 4.14 and a beta of 0.33. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter in the previous year, the business earned $0.92 earnings per share. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, July 20th were issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, July 20th. Colgate-Palmolive’s payout ratio is currently 84.13%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John T. Cahill sold 4,170 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This trade represents a 12.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 175,191 shares of company stock worth $16,110,903 over the last three months. 0.43% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. UBS Group raised their price target on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the stock a “buy” rating in a report on Monday, August 3rd. Citigroup lifted their target price on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. Morgan Stanley restated an “overweight” rating and issued a $104.00 price target on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $99.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE:CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its products are sold in more than 200 countries and territories through retail stores, e-commerce channels and professional networks.

The company’s portfolio includes Colgate toothpaste, toothbrushes and mouthwashes; Palmolive and Softsoap personal care products; Ajax and other household cleaning products; and Hill’s Science Diet and Prescription Diet pet foods.